LumiraDx UK Limited

Collection of Blood Samples for New Diagnostic Devices 2

Role: lead

Cobas® Lumira Collection of Venous and Capillary Blood Samples for the Research, Optimization and Calibration of New Diagnostic Devices

Role: lead

Performance Evaluation of the LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B Tests at Point of Care (POC) Sites

Role: lead

Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test

Role: lead

A Performance Evaluation of the Lumiradx Point of Care HbA1c Device

Role: lead

COVID-19: A POC Test Under Research & Evaluation

Role: lead

Evaluation of the LumiraDx Point of Care D-Dimer and CRP Tests

Role: lead

Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test

Role: lead

A Performance Evaluation of the LumiraDx Point of Care CRP Assay

Role: lead

Performance Evaluation of the LumiraDx SARS-CoV-2 & FLU A/B and SARS-CoV-2 & RSV Tests for Aid in the Assessment of COVID-19

Role: lead

Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and/or Influenza B (Flu B)

Role: lead

Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites

Role: lead

Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag ULTRA Test (ASPIRE-2)

Role: lead

Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test

Role: lead

A Performance Evaluation of the LumiraDx Point Of Care D-dimer Assay

Role: lead

Evaluation of the Accuracy of INR Results From Patients Taking Phenprocoumon as Anticoagulant When Measured Using the Lumiradx INR Test

Role: lead

Evaluation of Precision and Accuracy of INR Measurements in a Point of Care Device (OPTIMAL)

Role: lead